文献速递瓣膜外科

EACTS-STS-AATS人工心脏瓣膜标签工作组:瓣膜特征与标签问题

Characteristics of surgical prosthetic heart valves and problems around labelling: a document from the European Association for Cardio-Thoracic Surgery (EACTS)-The Society of Thoracic Surgeons (STS)-American Association for Thoracic Surgery (AATS) Valve Labelling Task Force.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

该文由EACTS、STS和AATS联合成立的人工瓣膜标签工作组撰写,基于2018年2月巴黎会议讨论,指出当前人工瓣膜尺寸标注和标签存在争议,导致不同瓣膜难以比较。工作组识别了物理尺寸报告、尺寸确定与标注、体内外测试及血流动力学性能报告等需改进领域,强调需加强利益相关方合作与ISO标准应用,为外科医生提供充分信息以优化瓣膜选择。

要点

  • 人工瓣膜尺寸和标签不统一导致临床比较困难。
  • 需规范瓣膜物理尺寸、尺寸标注及血流动力学性能报告。
  • 应加强监管机构、标准组织与厂商合作以改进现状。

核心结论

  • 当前人工心脏瓣膜尺寸标注和标签存在争议,需进一步标准化以利于瓣膜比较和选择。

研究设计与样本

  • EACTS-STS-AATS联合成立瓣膜标签工作组,成员包括心脏外科医生、心脏病专家、工程师、监管者及ISO和主要瓣膜制造商代表,于2018年2月在巴黎举行首次面对面会议,本文基于会议讨论形成。

主要发现

  • 工作组识别了需改进和澄清的领域:人工瓣膜物理尺寸和特性的报告、瓣膜尺寸的确定与标注、体内外测试及血流动力学性能和致血栓性的报告。
  • 需深入理解监管背景和适用ISO标准的作用,并加强所有利益相关方(包括监管和标准制定机构)之间的合作。

临床怎么用

  • 心脏外科医生应获得适当信息以优化人工瓣膜选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Intraoperative surgical prosthetic heart valve (SHV) choice is a key determinant of successful surgery and positive postoperative outcomes. Currently, many controversies exist around the sizing and labelling of SHVs rendering the comparison of different valves difficult. To explore solutions, an expert Valve Labelling Task Force was jointly initiated by the European Association for Cardio-Thoracic Surgery (EACTS), The Society of Thoracic Surgeons (STS) and the American Association for Thoracic Surgery (AATS). The EACTS-STS-AATS Valve Labelling Task Force, comprising cardiac surgeons, cardiologists, engineers, regulators and representatives from the International Organization for Standardization (ISO) and major valve manufacturers, held its first in-person meeting in February 2018 in Paris, France. This article was derived from the meeting's discussions. The Task Force identified the following areas for improvement and clarification: reporting of physical dimensions and characteristics of SHVs determining and labelling of SHV size, in vivo and in vitro testing and reporting of SHV haemodynamic performance and thrombogenicity. Furthermore, a thorough understanding of the regulatory background and the role of the applicable ISO standards, together with close cooperation between all stakeholders (including regulatory and standard-setting bodies), is necessary to improve the current situation. Cardiac surgeons should be provided with appropriate information to allow for optimal SHV choice. This first article from the EACTS-STS-AATS Valve Labelling Task Force summarizes the background of SHV sizing and labelling and identifies the most important elements where further standardization is necessary.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Durko AP, Head SJ, Pibarot P, et al. Characteristics of surgical prosthetic heart valves and problems around labelling: a document from the European Association for Cardio-Thoracic Surgery (EACTS)-The Society of Thoracic Surgeons (STS)-American Association for Thoracic Surgery (AATS) Valve Labelling Task Force. Eur J Cardiothorac Surg. 2019. PMID: 31075173. doi:10.1093/ejcts/ezz034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。